pyrrolidine dithiocarbamate has been researched along with bortezomib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gullbo, J; Larsson, R; Lövborg, H; Nygren, P; Oberg, F; Rickardson, L | 1 |
| Aydin, NE; Celik, O; Elter, K; Gurates, B; Hascalik, S; Tagluk, ME | 1 |
| Cvek, B | 1 |
| Deckard, LA; Logsdon, NJ; Sontheimer, H; Spiller, SE | 1 |
| Bhaskaran, S; Gupta, A; McCluskey, B; Muñoz, S; Oyajobi, BO; Sharma, R; Williams, PJ | 1 |
5 other study(ies) available for pyrrolidine dithiocarbamate and bortezomib
| Article | Year |
|---|---|
Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.
Topics: Alcohol Deterrents; Blotting, Western; Boronic Acids; Bortezomib; Cell Line; Cell Nucleus; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Cycloheximide; Disulfiram; Dose-Response Relationship, Drug; Humans; NF-kappa B; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Transport; Pyrazines; Pyrrolidines; Thiocarbamates; Tumor Necrosis Factor-alpha | 2006 |
Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Topics: Animals; Antigens, CD34; Azo Compounds; Boronic Acids; Bortezomib; Case-Control Studies; Endometriosis; Eosine Yellowish-(YS); Female; Ki-67 Antigen; Methyl Green; NF-kappa B; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyrrolidines; Rats; Thiocarbamates | 2008 |
Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways.
Topics: Animals; Boronic Acids; Bortezomib; Endometriosis; Female; Mice; NF-kappa B; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyrrolidines; Thiocarbamates | 2009 |
Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.
Topics: Animals; Boronic Acids; Bortezomib; Cell Growth Processes; Cell Line, Tumor; Cerebellar Neoplasms; Curcumin; Ditiocarb; Humans; I-kappa B Proteins; Medulloblastoma; Mice; Mice, Inbred C57BL; Mice, Nude; NF-kappa B; Pyrazines; Pyrrolidines; Signal Transduction; Sulfasalazine; Thiocarbamates; Transgenes; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.
Topics: Animals; Apoptosis; beta Catenin; beta-Transducin Repeat-Containing Proteins; Bone Marrow; Bone Marrow Cells; Bortezomib; Caspase 3; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Female; Genes, Dominant; Humans; Mice; Mice, Inbred C57BL; Multiple Myeloma; Mutation; Neoplasm Transplantation; Proteasome Endopeptidase Complex; Pyrrolidines; Stromal Cells; Thiocarbamates; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2015 |